Notice NOT-CA-18-060 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-18-742 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to encourage research that investigates the role of molecular epigenetic or non-coding RNA regulatory pathways in the development or maintenance of chronic pain. Ultimately research in the area will provide foundational knowledge that can be exploited to develop novel and non-addictive pain medications.

Funding Opportunity PA-18-741 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushings diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition; kidney, urologic, and hematologic diseases. The goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets or data, for which the primary goal is data analysis and not preparation/presentation of data.

Negotiable: Paramount Recruitment: Head of Software Engineering (Bioinformatics) A brilliant new opportunity has just become available for a Head of Software Engineering to join the UK's top Consumer Genetic Testing company. Frome, England

Funding Opportunity RFA-RM-18-011 from the NIH Guide for Grants and Contracts. The overarching goal of this FOA is to add informatics capabilities to the Common Fund program, Illuminating the Druggable Genome (IDG; https://commonfund.nih.gov/idg/index). The IDG consortium's purpose is to facilitate the unveiling of the functions of selected understudied proteins in the Druggable Genome using experimental and informatics approaches. Currently, this research consortium is composed of multiple Data and Resource Generation Centers (DRGCs), a Knowledge Management Center (KMC), and a Resource Dissemination and Outreach Center (RDOC). The purpose of this specific FOA is to solicit applications to build a set of Cutting Edge Informatics Tools (CEITs) that will augment the capability of the KMC as well as the broader IDG Consortium in two ways: (1) by deploying tools to enhance the communitys ability to process, analyze, visualize data, to prioritize new data resources and methods to be incorporated into Pharos that will strengthen predictions about physiological and disease associations around the understudied proteins and (2) to prioritize physiological and disease relevant cellular and animal models for further study of the understudied proteins (non-olfactory GPCRs, protein kinases, and ion channels) both within the IDG program and by the larger community.

Funding Opportunity PAR-18-740 from the NIH Guide for Grants and Contracts. This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the scholar can be considered to remain as an investigator within the intramural program

Funding Opportunity PA-18-738 from the NIH Guide for Grants and Contracts. The overall purpose of this funding opportunity announcement (FOA) is to assess the role of the microbiome in health and disease during aging. This initiative will support research projects designed to evaluate changes in the microbiota during lifetime and its influence in health and disease status in the elderly, including those from racial/ethnic minority and underserved populations and understand the underlying mechanisms of microbiota interactions in aged subjects as related to health and disease. This FOA will accept basic mechanistic, preclinical studies in animal models and human clinical trial proposals in accordance with the state of the science.

Funding Opportunity PA-18-739 from the NIH Guide for Grants and Contracts. The overall purpose of this funding opportunity announcement (FOA) is to assess the role of the microbiome in health and disease during aging. This initiative will support research projects designed to evaluate changes in the microbiota during lifetime and its influence in health and disease status in the elderly, including those from racial/ethnic minority and underserved populations and understand the underlying mechanisms of microbiota interactions in aged subjects as related to health and disease. This FOA will accept basic mechanistic, preclinical studies in animal models and human clinical trial proposals in accordance with the state of the science.

Notice NOT-CA-18-056 from the NIH Guide for Grants and Contracts

£39,992 - £49,149 per annum (potential to progress to £52,132 per annum...): Queens University Belfast (QUB): The Precision Medicine Centre of Excellence (PMC) at Queen’s University Belfast is a new clinical laboratory bringing together high-throughput... Belfast (County) (GB)

Notice NOT-NS-18-054 from the NIH Guide for Grants and Contracts

<p><strong></strong><p><strong></strong><p><strong>Job Responsibilities:</strong><ul><li>Develop, implement and refine strategic program plan for the Pipeline...
From Adaptive Biotechnologies - Tue, 03 Apr 2018 06:40:59 GMT - View all Seattle, WA jobs

Funding Opportunity RFA-RM-18-006 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications from the Program Directors/Principal Investigators of the current Building Infrastructure Leading to Diversity (BUILD) awards. BUILD is part of the Enhancing the Diversity of the NIH-Funded Workforce Program, also known as the Diversity Program Consortium (DPC), consists of three integrated initiatives: BUILD, the National Research Mentoring Network (NRMN) and the Coordination and Evaluation Center (CEC). The purpose of the funding is to allow BUILD sites to continue to implement and evaluate the multi-pronged student, faculty, and institutional interventions to enhance diversity in the NIH biomedical research workforce. In preparation for the second phase of the BUILD initiative, the applicants are expected to provide plans to transition into sustainable models for enhancing diversity in the biomedical research fields at their institutions. Applicants are also expected to develop an effective training, mentoring, or research capacity building intervention that will be disseminated to other institutions to increase the national impact of the initiative.

Funding Opportunity RFA-DK-18-005 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages applications from integrative teams and individual investigators for projects to determine the mechanisms underlying the contribution of these risk-associated genes and their variants for T1D. The purpose is to accelerate the discovery of function of the causal genes and variants that influence the risk for disease.

Hands on experience with DNA and RNA preparations, PCR, restriction analysis, and cloning is required....
From Fred Hutchinson Cancer Research Center - Tue, 03 Apr 2018 04:38:39 GMT - View all Seattle, WA jobs

Familiarity with cell-based assays, bioinformatics, display platforms, next generation sequencing, kinetic binding assays or cancer biology a plus....
From Seattle Genetics, Inc. - Tue, 03 Apr 2018 01:52:36 GMT - View all Bothell, WA jobs

Notice NOT-DE-18-016 from the NIH Guide for Grants and Contracts

Notice NOT-DA-18-010 from the NIH Guide for Grants and Contracts

Notice NOT-DE-18-014 from the NIH Guide for Grants and Contracts

Notice NOT-CA-18-061 from the NIH Guide for Grants and Contracts